PYC pyc therapeutics limited

Ann: PYC Increases Shareholding in Vision Pharma, page-5

  1. 952 Posts.
    lightbulb Created with Sketch. 191
    LEI is not for profit, they are the silent IP (risk free) seed partner - PYC is the financial and commercial partner.

    That seed is now $18.5m and 6.5% royalty/share of profits to perpetuity for:
    - VP-001: ~$50m annually
    - VP-002: ~$50m annually

    This annual passive income ~$100m will help fund their future research, is what their after.

    The muted valuation of VP reflects current market sentiment/mc of PYC - but reflects the fundamental scientific work vs last valuation - probability rising.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.30
Change
-0.025(1.89%)
Mkt cap ! $755.3M
Open High Low Value Volume
$1.32 $1.32 $1.30 $478.1K 365.3K

Buyers (Bids)

No. Vol. Price($)
1 2000 $1.29
 

Sellers (Offers)

Price($) Vol. No.
$1.32 10000 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.